Alexander P. Adler

发表

Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models

Gavin Thurston, Yi Wei, Yi Wei, 2012, Angiogenesis.

Abstract 3290: REGN910, a fully-human, Ang2-specific monoclonal antibody, inhibits tumor growth as a monotherapy and dramatically potentiates the effects of VEGF Trap (aflibercept)

A. Eichten, N. Papadopoulos, G. Thurston, 2011 .

Single-Cell Transcriptome Analyses Reveal Endothelial Cell Heterogeneity in Tumors and Changes following Antiangiogenic Treatment.

M. Ni, Yi Wei, Christina Adler, 2018, Cancer research.

Resistance to Anti-VEGF Therapy Mediated by Autocrine IL6/STAT3 Signaling and Overcome by IL6 Blockade.

Hsin C. Lin, G. Yancopoulos, I. Lowy, 2016, Cancer research.

Heterogeneity and chimerism of endothelial cells revealed by single-cell transcriptome in orthotopic liver tumors

G. Atwal, M. Ni, Yi Wei, 2020, Angiogenesis.

Abstract 2723: Sarilumab (REGN88), a fully-human anti-IL6R antibody, inhibits tumor growth in preclinical models, as a single agent and in combination with the VEGF blocker aflibercept

A. Eichten, G. Thurston, C. Daly, 2012 .

Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition.

Alastair H Kyle, Gavin Thurston, G. Yancopoulos, 2013, Cancer research.

Rapid decrease in tumor perfusion following VEGF blockade predicts long-term tumor growth inhibition in preclinical tumor models

Yi Wei, G. Yancopoulos, A. Eichten, 2012, Angiogenesis.